表紙
市場調查報告書

醫藥品、醫療設備組合產品市場 - 規模、佔有率、展望、機會分析 (2020-2027年):各產品類型、地區

Drug-Device Combination Products Market, By Product Type, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品編碼 948358
出版日期 內容資訊 英文 185 Pages
商品交期: 2-3個工作天內
價格
醫藥品、醫療設備組合產品市場 - 規模、佔有率、展望、機會分析 (2020-2027年):各產品類型、地區 Drug-Device Combination Products Market, By Product Type, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年06月16日內容資訊: 英文 185 Pages
簡介

醫藥品、醫療設備組合產品,透過特殊的設備施用給患者或由輸送的藥物構成。那樣的產品範例中,包含預填充式注射器,輸液幫浦,支架等的藥物表面塗層的設備等。

本報告提供全球醫藥品、醫療設備組合產品市場相關調查,市場概要,影響市場的因素分析,各市場區隔、各地區的市場分析,並提供主要企業簡介等資訊。

第1章 調查目的、前提條件

第2章 市場範圍

  • 報告的說明
  • 市場定義和範圍
  • 摘要整理
  • 市場明細:各產品類型
  • Coherent Opportunity Map (COM)

第3章 市場動態,法規,趨勢分析

  • 市場動態
  • 促進因素
  • 阻礙因素
  • 市場機會
  • 影響分析
  • 主要的發展
  • 技術進步
  • 法規方案

第4章 全球醫藥品、醫療設備組合產品市場:各產品類型

  • 簡介
  • 市場佔有率分析
  • 與前一年同期比較成長分析
  • 市場區隔趨勢
  • 藥劑溶出性血管支架
  • 簡介
  • 市場規模與預測,及與前一年同期比較成長
  • 市場區隔趨勢
  • 冠狀動脈支架
  • 末梢血管支架
  • 輸液幫浦
  • 簡介
  • 市場規模與預測,及與前一年同期比較成長
  • 市場區隔趨勢
  • 置入式
  • 門診病人
  • 光敏化劑
  • 簡介
  • 市場規模與預測,及與前一年同期比較成長
  • 市場區隔趨勢
  • 整形外科用組合產品(骨移植片植入+抗生素配合骨水泥)
  • 簡介
  • 市場規模與預測,及與前一年同期比較成長
  • 市場區隔趨勢
  • 創傷護理配合商品
  • 簡介
  • 市場規模與預測,及與前一年同期比較成長
  • 市場區隔趨勢
  • 吸入器
  • 簡介
  • 市場規模與預測,及與前一年同期比較成長
  • 市場區隔趨勢
  • 噴霧器
  • MDI
  • DPI
  • 經皮吸收貼片
  • 簡介
  • 市場規模與預測,及與前一年同期比較成長
  • 市場區隔趨勢
  • 其他(眼內植入,釋藥微球)
  • 簡介
  • 市場規模與預測,及與前一年同期比較成長
  • 市場區隔趨勢

第5章 全球醫藥品、醫療設備組合產品市場:各地區

    • 簡介
    • 市場佔有率分析
    • 與前一年同期比較成長分析
    • 市場區隔趨勢
    • 北美
    • 簡介
    • 市場規模與預測,及與前一年同期比較成長
    • 美國
    • 加拿大
    • 歐洲
    • 簡介
    • 市場規模與預測,及與前一年同期比較成長
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲
    • 亞太地區
    • 簡介
    • 市場規模與預測,及與前一年同期比較成長
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 其他亞太地區
    • 南美
    • 簡介
    • 市場規模與預測,及與前一年同期比較成長
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他南美國家
    • 中東
    • 簡介
    • 市場規模與預測,及與前一年同期比較成長
    • GCC
    • 以色列
    • 其他中東
    • 非洲
    • 簡介
    • 市場規模與預測,及與前一年同期比較成長
    • 北非
    • 中非
    • 南非

第6章 競爭情形

  • 企業簡介
  • Teva Pharmaceutical Industries Ltd.
  • 公司概要
  • 產品系列
  • 主要的發展
  • 財務成果
  • 策略
  • Becton, Dickinson and Company
  • Integer Holdings Corporation
  • Abbott Laboratories
  • Medtronic plc
  • Allergan, Inc.
  • Alcon, Inc.
  • Arrow International,Inc.
  • Bausch&Lomb,Inc.
  • Boston Scientific Corporation
  • 其他的主要企業

第7章 Section

目錄

Title:
Drug-Device Combination Products Market, By Product Type (Drug Eluting Stents (Coronary stent, Peripheral Vascular stents), Infusion pumps (Implantable, Ambulatory), Photosensitizers, Orthopedic combination products (Bone graft imlants + antibiotic loaded bone cements), Wound care combination products, Inhalers (Nebulizers, MDI, DPI), Transdermal patches, Others( Intraocular implants, drug eluting beads)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Drug device combination products consists of drugs administered or delivered through a specialized devices to the patients. Examples of such products include prefilled syringes, infusion pumps, drug coated devices such as stents, and others. Manufacturers such as Teva Pharmaceutical Industries Ltd., Becton, Dickinson and Company, Integer Holdings Corporation, Abbott Laboratories, and others offer drug device combination products in the market.

Restraints of the Global Drug-Device Combination Products Market

Major factors hampering the growth of the drug-device combination products market during the forecast period constitutes of presence of stringent and non-specific regulatory pathway and risks associated with infections.

Key features of the study:

  • This report provides in-depth analysis of the global drug-device combination products market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019-2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global drug-device combination products market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Becton, Dickinson and Company, Integer Holdings Corporation, Abbott Laboratories, Medtronic plc, Allergan, Inc., Alcon, Inc., Arrow International, Inc., Bausch & Lomb, Inc., Boston Scientific Corporation, ALK, SINOMED, Kaleo, Haselmeier, Flowonix Medical, Inc., CareFusion Corporation, and Covidien PLC
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global drug-device combination products market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global Drug-Device Combination Products Market, By Product Type:
  • Drug Eluting Stents
  • Coronary stent
  • Peripheral Vascular stents
  • Infusion pumps
  • Implantable
  • Ambulatory
  • Photosensitizers
  • Orthopedic combination products (Bone graft imlants + antibiotic loaded bone cements)
  • Wound care combination products
  • Inhalers
  • Nebulizers
  • MDI
  • DPI
  • Transdermal patches
  • Others( Intraocular implants, drug eluting beads)
  • Global Drug-Device Combination Products Market, By Geography:
  • North America
  • By Product Type
  • Drug Eluting Stents
    • Coronary stent
    • Peripheral Vascular stents
  • Infusion pumps
    • Implantable
    • Ambulatory
  • Photosensitizers
  • Orthopedic combination products (Bone graft imlants + antibiotic loaded bone cements)
  • Wound care combination products
  • Inhalers
    • Nebulizers
    • MDI
    • DPI
  • Transdermal patches
  • Others( Intraocular implants, drug eluting beads
  • By Country:
  • U.S.
  • Canada
  • Europe
  • By Product Type
  • Drug Eluting Stents
    • Coronary stent
    • Peripheral Vascular stents
  • Infusion pumps
    • Implantable
    • Ambulatory
  • Photosensitizers
  • Orthopedic combination products (Bone graft imlants + antibiotic loaded bone cements)
  • Wound care combination products
  • Inhalers
    • Nebulizers
    • MDI
    • DPI
  • Transdermal patches
  • Others( Intraocular implants, drug eluting beads
  • By Country:
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Product Type
  • Drug Eluting Stents
    • Coronary stent
    • Peripheral Vascular stents
  • Infusion pumps
    • Implantable
    • Ambulatory
  • Photosensitizers
  • Orthopedic combination products (Bone graft imlants + antibiotic loaded bone cements)
  • Wound care combination products
  • Inhalers
    • Nebulizers
    • MDI
    • DPI
  • Transdermal patches
  • Others( Intraocular implants, drug eluting beads
  • By Country:
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • By Product Type
  • Drug Eluting Stents
    • Coronary stent
    • Peripheral Vascular stents
  • Infusion pumps
    • Implantable
    • Ambulatory
  • Photosensitizers
  • Orthopedic combination products (Bone graft imlants + antibiotic loaded bone cements)
  • Wound care combination products
  • Inhalers
    • Nebulizers
    • MDI
    • DPI
  • Transdermal patches
  • Others( Intraocular implants, drug eluting beads
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East:
  • By Product Type
  • Drug Eluting Stents
    • Coronary stent
    • Peripheral Vascular stents
  • Infusion pumps
    • Implantable
    • Ambulatory
  • Photosensitizers
  • Orthopedic combination products (Bone graft imlants + antibiotic loaded bone cements)
  • Wound care combination products
  • Inhalers
    • Nebulizers
    • MDI
    • DPI
  • Transdermal patches
  • Others( Intraocular implants, drug eluting beads
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Product Type
  • Drug Eluting Stents
    • Coronary stent
    • Peripheral Vascular stents
  • Infusion pumps
    • Implantable
    • Ambulatory
  • Photosensitizers
  • Orthopedic combination products (Bone graft imlants + antibiotic loaded bone cements)
  • Wound care combination products
  • Inhalers
    • Nebulizers
    • MDI
    • DPI
  • Transdermal patches
  • Others( Intraocular implants, drug eluting beads
  • By Country/Region:
  • Central Africa
  • South Africa
  • North Africa
  • Company Profiles
  • Teva Pharmaceutical Industries Ltd.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
  • Becton, Dickinson and Company
  • Integer Holdings Corporation
  • Abbott Laboratories
  • Medtronic plc
  • Allergan, Inc.
  • Alcon, Inc.
  • Arrow International, Inc.
  • Bausch & Lomb, Inc.
  • Boston Scientific Corporation
  • Other Major Players

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations

2. Market Purview

    • Report Description
    • Market Definition and Scope
    • Executive Summary
    • Market Snippet, By Product Type
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Technological Advancement
    • Regulatory Scenario

4. Global Drug-Device Combination Products Market, By Product Type, 2017 - 2027 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2019-2027
    • Segment Trends
    • Drug Eluting Stents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends
    • Coronary stent
    • Peripheral Vascular stents
    • Infusion pumps
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends
    • Implantable
    • Ambulatory
    • Photosensitizers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends
    • Orthopedic combination products (Bone graft imlants + antibiotic loaded bone cements)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends
    • Wound care combination products
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends
    • Inhalers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends
    • Nebulizers
    • MDI
    • DPI
    • Transdermal patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends
    • Others( Intraocular implants, drug eluting beads)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends

5. Global Drug-Device Combination Products Market, By Regions, 2017 - 2027 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2019-2027
    • Segment Trends
    • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • U.S.
    • Canada
    • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

6. Competitive Landscape

    • Company Profiles
    • Teva Pharmaceutical Industries Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Becton, Dickinson and Company
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Integer Holdings Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Medtronic plc
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Allergan, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Alcon, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Arrow International, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Bausch & Lomb, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Boston Scientific Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Other Major Players
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

7. Section

    • References
    • Research Methodology
    • About us and Sales Contact